TriReme touts FDA okay for more Chocolate PTA balloon catheters
Maquet Cardiovascular LLC
Boston Scientific’s Innova peripheral stent débuts in Europe | Regulatory Roundup
Boston Scientific (NYSE:BSX) said it plans to get its Innova stent for peripheral artery disease on the market in the European Union "immediately" now that it’s won CE Mark approval there.
New FDA rules imperil Bioject | Wall Street Beat
ACC roundup: The top headlines from today’s meeting of American College of Cardiology
Maquet restructures to meet shifting OR needs
Getinge Group subsidiary Maquet restructured the organization of its U.S. sales and services to meet the growing hybrid operating room market.
Hybrid OR’s contain both a traditional operating room and a cardiac catheterization lab, minimizing the need to move a sick patient from room to room for complex procedures.
The suites are designed to foster collaboration between cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons and build a more efficient workflow.
GE Healthcare begins PMA process for 3D breast scanner | Regulatory Roundup
GE Healthcare (NYSE:GE) filed the first module of its pre-market approval application for the breast tomosynthesis option of its Senographe Essential system.
The health care giant said the first submission included a device description and non-clinical information, including "phantom testing," and detector performance evaluation. The system is intended as an add-on option for the Senographe Essential to produce 3D images for screening and diagnosis of breast cancer.
J&J unit completes SterilMed acquisition | Acquisitions Roundup
Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery division finished its acquisition of Minnesota-based medical device reprocessor SterilMed Inc for an undisclosed amount.
SterilMed reprocesses medical devices and provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.
Maquet inks GPO deal with Premier
Getinge Group (STO:GETI B) subsidiary Maquet Cardiovascular inked a three-year contract with U.S. group purchasing organization Premier Healthcare Alliance for its intra-aortic balloon pumps.
The contract includes Maquet’s CS300 product line, as well as its Mega, Sensation, and Linear catheters used to treat acute heart failure, irregular heart rhythms and other cardiac problems.
Maquet’s Sensation Plus aortic balloon catheter won FDA approval and CE Mark clearance late last month.
Maquet Cardiovascular awarded three-year contract from premier healthcare alliance for intra-aortic balloon pumps
WAYNE, N.J., Oct. 10, 2011 /PRNewswire/ — MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has signed a three-year, dual-source contract with Premier Healthcare Alliance to provide intra-aortic balloon pumps (IABP) to the Premier membership. The contract includes the CS300 product line, as well as the MEGA™ 8Fr. 50cc IABP Catheter, SENSATION® 7Fr. IABP Catheter and LINEAR™ 7.5Fr. IABP Catheter, which are used in the treatment of cardiogenic shock, acute heart failure, irregular heart rhythms, cardiac surgery, and percutaneous coronary intervention. This contract represents the seventh such contract with Premier covering a wide range of MAQUET Cardiovascular’s product lines.
Getinge Group pays $680 million for Atrium Medical | Acquisitions Roundup
Sweden-based Getinge Group announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton, according to a press release.
Getinge Group and subsidiary Maquet Cardiovascular sign agreement to acquire Atrium Medical for $680 Million
— Atrium’s products strategically augment MAQUET Cardiovascular’s global business —
WAYNE, N.J., Oct. 3, 2011 /PRNewswire/ — GETINGE GROUP (STO:GETIB) and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technologies, announced today that it has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million. Atrium is a leader in medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Atrium will operate as an independent, self-contained business unit of MAQUET Cardiovascular and will be led by current Atrium president, Trevor Carlton.
